{"filings":[{"id":2132838,"accession_number":"0001437749-26-026573","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-08-07T20:01:29+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 EPS $0.15 vs $0.05; record backlog $117.5M, gross margin up 500 bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $47.9M, down 1.3% YoY; gross margin 28.9% vs 23.9% (incl. $1.1M IEEPA refund).","GAAP EPS $0.15 vs $0.05; adjusted EBITDA $6.1M vs $4.1M.","Backlog $117.5M, record high, up from $115.1M Q1 and $84.5M year ago.","Communications Systems sales up 39.3% to $3.8M; Battery & Energy down 3.7% to $44.2M.","One-time costs $0.9M (litigation for cyber-insurance claim, consulting); 45X tax credit partially offsets interest."],"consensus_eps_estimate":null,"consensus_eps_actual":13.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":95388000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1830316,"accession_number":"0001437749-26-024330","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-07-23T20:27:00+00:00","items":["5.07"],"status":"ready","headline":"Ultralife stockholders re-elect all five directors, ratify auditor, approve say-on-pay at 2026 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All five director nominees elected with >10.9M votes for each; broker non-votes ~2.7M.","Ratification of WithumSmith+Brown as independent auditor for 2026: 13.83M for, 137k against.","Advisory vote on executive compensation approved: 10.97M for, 245k against.","Non-binding preference for say-on-pay frequency: 8.55M voted for 3 years; board adopts 3-year frequency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99342,"accession_number":"0001437749-26-015749","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 revenue $47.4M, GAAP EPS -$0.03; backlog record $115.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $47.4M, down 6.5% YoY; Battery & Energy sales -4.7%, Communications Systems -25.7%.","GAAP net loss ($0.5M) or ($0.03) per share vs $1.9M/$0.11 prior year; adjusted EBITDA $3.2M vs $5.4M.","Gross margin 21.3% (down from 25.1%); operating loss ($0.2M) including $1.7M one-time costs from power outage, inventory integration, and weather.","Backlog record $115.1M, highest ever, up from $110.2M at Q4 2025 and $95.0M at Q1 2025.","Management focusing on improving manufacturing efficiencies and driving orders to restore profitability and generate cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":47445000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115278,"accession_number":"0001437749-26-007567","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $48.5M (+10.6% YoY); operating loss ($10.6M) vs profit $1.5M last year, driven by $12.2M intangible asset impairment.","GAAP EPS ($0.45) includes ($0.57) impairment charge; adjusted EBITDA $5.7M (11.7% sales) vs $3.9M.","Battery & Energy sales $45.9M (+15.1% YoY); Communications Systems $2.6M (-35.2%).","Backlog $110.2M (+22% from Q3); management expects improved 2026 results.","Rebranding consolidates sub-brands under Ultralife; expects $1.4M tax credit under 45X."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131691,"accession_number":"0001437749-25-035515","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 sales up 21.5% to $43.4M; GAAP loss per share of $0.07 on Calgary closure charge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $43.4M (+21.5% YoY, including Electrochem); organic growth 2.5%. Backlog $90.1M vs $84.5M at Q2 2025.","GAAP EPS ($0.07) vs $0.02; operating loss $1.0M includes $1.1M non-recurring costs (Calgary facility closure).","Gross margin 22.2% down from 24.3% on raw material quality issues; adjusted EBITDA $2.0M vs $1.9M.","Battery & Energy Products sales +22.8% (ex-Electrochem +1.9%); government/defense sales +19.0%.","Calgary closure charge $0.5M; expected annual savings ~$0.8M after completion in Q1 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":142678000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148260,"accession_number":"0001437749-25-027836","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Ultralife replaces auditor Freed Maxick with Withum Smith+Brown effective immediately","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Auditor change due to acquisition of certain assets of Freed Maxick by Withum Smith+Brown.","Prior auditor's reports for FY2023 and FY2024 had no adverse opinions or qualifications.","FY2024 internal control opinion did note a material weakness in internal control over financial reporting.","No disagreements or reportable events with Freed Maxick during the relevant periods.","Audit committee engaged Withum as the new independent auditor for FY2025 effective August 22, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148259,"accession_number":"0001437749-25-025482","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 revenue up 13% to $48.6M on Electrochem; margin down, GAAP EPS $0.05 vs $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $48.6M (+13% YoY); organic Battery & Energy flat, Communications Systems down 57.2% to $2.7M.","Gross margin fell to 23.9% from 26.9% due to product mix, tariffs, and lower factory throughput.","Operating income $2.3M vs $3.9M; GAAP EPS $0.05 vs $0.18; adjusted EPS $0.07 vs $0.22.","Backlog with high-confidence orders $89M vs $95M at Q1 2025; debt prepaid $2.7M.","CEO expects improved results in H2 2025 on rebound in Communications and new product orders."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":99307000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148258,"accession_number":"0001437749-25-022930","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife stockholders elect directors and ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Met quorum with 14,196,720 shares (85.35%) out of 16,632,965 outstanding.","Elected directors: Michael Manna, Janie Goddard, Thomas Saeli, Robert Shaw II, Bradford Whitmore; all received overwhelming 'for' votes.","Ratified Freed Maxick P.C. as independent auditor for 2025: 14,042,572 for, 61,028 against, 21,888 abstain.","No shareholder proposals or contested matters were presented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167030,"accession_number":"0001437749-25-015629","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 revenue $50.7M (+21% YoY); GAAP EPS $0.11 vs $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $50.7M, up 21% YoY; Battery & Energy Products +32.4% to $46.3M (incl. Electrochem, organic +10.6%).","GAAP EPS $0.11 vs $0.18 YoY; adjusted EPS $0.13 vs $0.21; operating income $3.4M vs $4.1M.","Gross margin 25.1% (vs 27.4% YoY) on product mix; Communications Systems sales fell 36.2% to $4.4M.","Backlog $95.0M vs $102.2M at Q4 2024; company cites strong replenishment and tariff mitigation plan."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":50746000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167029,"accession_number":"0001437749-25-010359","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2025-04-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 GAAP EPS $0.01 vs $0.17 YoY; sales $43.9M; backlog $102.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $43.9M, down from $44.5M YoY; Battery & Energy +11.7%, Communications -55.1%.","GAAP EPS $0.01 ($0.2M net income) vs $0.17 ($2.9M) in Q4 2023; adjusted EPS also $0.01.","Operating income $1.5M including $1.1M one-time acquisition costs; adjusted EBITDA $3.9M.","Full-year sales $164.5M (+3.7%); GAAP EPS $0.38 vs $0.44; adjusted EBITDA $16.5M.","Backlog and high-confidence orders $102.2M at year-end 2024 vs $78.0M at Q3 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":50746000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184408,"accession_number":"0001437749-25-001267","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K/A","filed_at":"2025-01-16T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Ultralife files amended 8-K with audited financials for Electrochem acquisition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Ultralife Corporation (ULBI) filed an 8-K/A on Jan 16, 2025, amending its Nov 6, 2024 report.","The amendment adds audited financial statements of Electrochem Solutions as of Dec 31, 2023.","Pro forma unaudited combined financial information for Sep 30, 2024 and Dec 31, 2023 is included.","Electrochem was acquired from Integer Holdings Corp. (ITGR) on Oct 31, 2024.","Philip A. Fain signed the filing; exhibits include audited statements by Freed Maxick P.C."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201009,"accession_number":"0001437749-24-034046","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 EPS $0.02 vs $0.08; revenue $35.7M (-9.6%); backlog $78M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.02, down from $0.08; net income $0.3M vs $1.3M Q3 2023.","Revenue $35.7M, down 9.6% YoY; Battery & Energy +1.9%, Communications Systems -58.2%.","Backlog $78.0M; debt reduced 33.4% to $8.0M from $12.1M at Q2 end.","Acquisition of Electrochem Solutions completed Oct 31; related costs $0.3M in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":120604000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201008,"accession_number":"0001437749-24-033673","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["1.01","2.01","2.03","7.01","9.01"],"status":"ready","headline":"Ultralife completes $50M acquisition of Electrochem Solutions; secures $55M term loan","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all shares of Electrochem from Integer Holdings (NYSE: ITGR) for $50M cash on Oct 31, 2024.","Electrochem designs primary lithium metal and ultracapacitor cells; trailing 12-month revenue of $34M.","Funded via new $55M senior secured term loan from KeyBank, M&T, and Community Bank, maturing Oct 31, 2029.","CEO Mike Manna expects cross-selling opportunities, scale efficiencies, and expanded market reach.","Financial statements and pro forma financial information to be filed within 71 days of this report."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201007,"accession_number":"0001437749-24-030645","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-10-03T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Ultralife acquires Electrochem Solutions for $50M; expects EPS accretive in 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $50M cash; transaction expected to close by end of October 2024.","Electrochem had trailing 12-month revenue of $34M as of June 30, 2024.","Deal expected accretive on EPS basis for 2025; financed via amended credit facilities.","Khristine Carroll to join as SVP-GM of Electrochem upon closing.","Acquisition targets gross margin expansion through vertical integration and synergies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217014,"accession_number":"0001437749-24-023415","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 sales $43.0M (+0.7%); Battery segment record; debt cut 52% to $12.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $43.0M vs $42.7M; Battery & Energy Products segment record $36.7M, up 8.3% YoY.","Gross margin improved 210 bps to 26.9%; Battery gross margin up 480 bps to 27.1%.","GAAP EPS $0.18 vs $0.21 (last year included $0.07 ERC); Adjusted EPS $0.22.","Backlog $93.0M; reduced debt by $13.2M (52.2%) to $12.1M.","Received $0.2M preliminary insurance payment for 2023 cyberattack."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":84910000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217013,"accession_number":"0001437749-24-022896","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife shareholders approve 2024 LTIP, reject majority-vote proposal at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five directors elected with broker non-votes of ~2.5M shares each.","Ratification of Freed Maxick CPAs as auditor for 2024: 13.5M for, 98k against.","Approval of 2024 Long-Term Incentive Plan: 9.1M for, 1.9M against, 2.5M broker non-votes.","Shareholder proposal for majority vote to elect directors failed: 3.3M for, 7.6M against.","Quorum of 13.6M shares (81.68% of outstanding) present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236775,"accession_number":"0001437749-24-013119","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1 sales up 31.4% to $41.9M; GAAP EPS $0.18 vs -$0.02 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $41.9M (+31.4% YoY); government/defense sales +83.4%, medical battery sales +54.7%.","GAAP EPS $0.18 vs net loss $0.02; adjusted EPS $0.21. Operating income $4.1M vs breakeven.","Gross margin 27.4% vs 23.3% YoY; Battery & Energy margin 25.7% vs 22.9%.","Backlog $97.4M; adjusted EBITDA $5.2M (12.5% of sales) vs $1.2M (3.6%).","CEO cites gross margin initiatives and core product demand; expects profitable growth and cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":41927000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254383,"accession_number":"0001437749-24-004266","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 revenue $44.5M (+23.4% YoY); adjusted EPS $0.18 vs -$0.03","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 sales $44.5M, up 23.4% YoY; full-year sales $158.6M, up 20.3%.","Q4 operating income $3.6M vs $0.2M; full-year $9.5M vs $0.1M.","Q4 adjusted EPS $0.18 vs loss of $0.03; full-year adjusted EPS $0.52 vs loss of $0.07.","Medical battery sales highest quarter ever; Battery & Energy gross margin expanded 360 bps to 25.2%.","Backlog $103.5M at year-end; management plans to pay down acquisition debt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":158644000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271875,"accession_number":"0001437749-23-029034","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 sales $39.5M (+18.8% YoY); operating income $2.1M vs loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $1.3M ($0.08 diluted EPS) vs net loss of $0.2M a year ago.","Adjusted EPS $0.10 vs adjusted loss of $0.03 in Q3 2022.","Gross margin improved 460 bps to 24.8% on price realization and level-loaded production.","Government/defense sales up 48.1%; commercial sales up 5.6%.","Backlog $101.1M at quarter-end, with over $35M expected to ship in remaining 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":114096000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288722,"accession_number":"0001437749-23-020793","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 revenue $42.7M (+33% YoY); operating income $3.7M vs $0.8M; backlog record $110.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $42.7M, up 32.9% YoY; operating income $3.7M vs $0.8M YoY.","Adjusted EPS $0.29 vs $0.03 YoY; GAAP net income $3.3M ($0.21 diluted EPS).","Backlog reached record $110.9M, up 40.1% YoY; $76.4M expected to ship in H2 2023.","Government/defense sales up 111.5%; Communications Systems sales more than quadrupled to $8.8M.","Gross margin 24.8% vs 23.8% YoY; Battery & Energy margin declined to 22.3% due to cyber-attack effects."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":74608000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":288721,"accession_number":"0001437749-23-020436","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-07-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife shareholders elect all directors, approve say-on-pay, set advisory vote frequency at 3 years","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected with votes for ranging from 10.3M to 11.2M shares; broker non-votes of 2.35M on each.","Auditor Freed Maxick ratified with 13.57M for, 15.7K against, 15.0K abstain.","Advisory say-on-pay approved: 11.04M for, 162.8K against, 38.4K abstain, 2.35M broker non-votes.","Non-binding frequency vote: 8.39M favored 3 years; board subsequently adopted 3-year cycle for future votes.","Quorum of 13.60M shares (84.2%) present out of 16.14M outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":309358,"accession_number":"0001437749-23-011241","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q1: revenue $31.9M (+5.1%), net loss $0.3M due to ransomware disruption","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $31.9M, +5.1% YoY; operating income breakeven vs loss $0.3M last year.","Net loss $0.3M ($0.02/share) vs net loss $0.2M ($0.01/share) in Q1 2022.","Ransomware attack discovered Jan 25, 2023; no ransom paid; $0.1M cyber insurance deductible recorded.","Gov/defense sales +24.7%; Communications Systems sales +181.8% to $3.4M on vehicle-amplifier adaptor order.","Total backlog $108.1M, with $96.1M shippable in 9 months, up 30.2% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":31916000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":328084,"accession_number":"0001437749-23-005169","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-03-02T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Ultralife Q4 revenue up 52% to $36.1M; backlog record $111M; cyber incident caused 2-week disruption","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $36.1M (+51.9% YoY); operating profit $0.2M vs loss $1.2M; net loss $0.2M ($0.01/sh) vs loss $1.1M ($0.07).","Backlog $111M, highest ever, up 74% YoY.","Cyber incident discovered Jan 25, 2023; partial disruption, ~2 weeks downtime; no ransom paid; $100k deductible.","Adjusted EBITDA $2.0M vs loss $0.1M; gross margin 22.4% vs 22.3%.","Government/defense sales up 84%; commercial up 38%; Battery & Energy up 45%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":328083,"accession_number":"0001437749-23-004092","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ultralife appoints Janie Goddard as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Janie Goddard appointed to Ultralife Board effective February 21, 2023.","Goddard is Divisional CEO at Halma plc; previously led at Novanta, Welch Allyn, Covidien, Johnson & Johnson.","She will serve on Audit & Finance, Compensation & Management, and Corporate Development & Governance committees.","Goddard also serves on the board of Methode Electronics (NYSE: MEI).","Compensation follows standard non-employee director terms per 2022 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345743,"accession_number":"0001437749-22-027918","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-11-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Ultralife names Michael E. Manna President & CEO; Popielec departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael E. Manna appointed President & CEO and Board member effective November 22, 2022.","Manna has 30-year tenure at Ultralife; annual base salary increased to $375,000.","Michael D. Popielec resigns as CEO and director; no disagreement with Company.","Popielec remains as advisor through Jan 20, 2023; receives 12 months salary, prorated 2023 bonus, accelerated options, and health benefits.","CEO succession was planned; Manna retains leadership of Battery & Energy Products segment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345742,"accession_number":"0001437749-22-024877","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-10-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q3 rev up 53% to $33.2M; net loss narrows to $0.2M but gross margin slides","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $33.2M, up 53% YoY; net loss $0.2M ($0.01/share) vs loss $0.6M ($0.04) in Q3 2021.","Government/defense sales doubled YoY; backlog reached $106.2M, up 153% from prior year.","Gross margin fell to 20.2% from 23.5%, pressured by supply chain disruptions and cost inflation.","Battery & Energy Products revenue $28.6M (+43%); organic growth 8.5% after excluding Excell contribution.","Operating loss improved to $0.6M; adjusted EBITDA $1.3M (3.8% of sales) vs $0.3M (1.3%) a year ago."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":95733000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":345741,"accession_number":"0001437749-22-024875","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-10-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ultralife awarded $5.5M vehicle comms systems order from U.S. Army prime contractor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase order valued at about $5.5M from a global prime defense contractor for the U.S. Army.","Shipments are expected to commence and be completed in 2023.","Follow-on full-rate production order; CEO highlights effectiveness of new product development strategy.","Vehicle communications platform provides enhanced range of digital voice and data communications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":362157,"accession_number":"0001437749-22-022888","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-09-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ultralife receives $7.5M contract for A-320 amplifiers and mounts from international defense contractor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Contract valued at approximately $7.5 million to supply A-320 amplifiers and A-320HVA radio vehicle mounts.","Customer is a major international defense contractor for an ongoing government/defense modernization program.","Deliveries expected to begin Q4 2022 and continue through the first half of 2023.","CEO cites the award as evidence of success in broadening global presence with international allies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":362156,"accession_number":"0001437749-22-017937","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-07-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 revenue up 20% to $32.1M; net income falls to $0.5M from $0.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $32.1M (+20% YoY); net income $0.5M ($0.03 diluted EPS) vs $0.8M ($0.05) prior year.","Operating income $0.8M vs $1.1M; gross margin 23.8% vs 27.1% on supply chain disruption and inflation.","Battery & Energy sales +31.8% to $30.1M, boosted by Excell acquisition ($6.6M) and commercial growth; Communications Systems -49% to $2.0M on supply delays.","Adjusted EBITDA flat at $2.2M (6.8% of sales vs 8.2%).","CEO cites supply chain constraints delaying govt/defense shipments; expects continued challenges in H2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":62499000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":362155,"accession_number":"0001437749-22-017786","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Ultralife awarded $4.6M order for Vehicle Amplifier-Adaptors from defense contractor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchase order valued at approximately $4.6 million for Ultralife's Vehicle Amplifier-Adaptor (VAA) platform.","Order placed by a global prime defense contractor; shipments expected to commence in 2022.","VAA platform enhances soldier digital voice and data communications and operational flexibility.","CEO cites effectiveness of new product development strategy with strategic partners."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":362154,"accession_number":"0001437749-22-017510","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-07-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife shareholders elect all five directors, ratify auditor at 2022 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected with majority support; Ranjit C. Singh received 9.8M for vs 1.6M withheld.","Ratification of Freed Maxick CPAs as independent auditor approved: 13.66M for vs 15.8K against.","Quorum of 85% of outstanding shares (13.7M of 16.1M) present at July 20, 2022 meeting.","Directors elected to one-year terms until 2023 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381674,"accession_number":"0001437749-22-009967","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife reports Q1 net loss of $0.2M on revenue $30.4M; backlog grows to $91.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $30.4M (+16.9% YoY); net loss $0.2M ($0.01 diluted) vs net income $0.7M ($0.04) in Q1 2021.","Battery & Energy Products sales up 31.8% to $29.2M, including $6.4M from Excell acquisition.","Communications Systems sales down 68.3% to $1.2M due to supply chain disruptions delaying shipments.","Gross margin fell to 22.9% from 26.9% on input cost inflation and higher logistics costs.","Backlog reached $91.9M; $73.8M expected to ship in 2022, up 26% from prior quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":30373000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":381673,"accession_number":"0001437749-22-010075","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K/A","filed_at":"2022-04-28T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Ultralife amends Excell acquisition filing to include unqualified audit opinion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audited financial statements of Excell now include unqualified opinion from MNP LLP.","Excell reported $18.46M in sales and $1.49M net income for period Feb 1, 2021 to Dec 12, 2021.","Total assets of $9.0M and stockholders' equity of $6.45M as of Dec 12, 2021.","Amendment No. 2 corrects prior qualified audit opinion; no other changes to prior filings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399660,"accession_number":"0001437749-22-004686","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K/A","filed_at":"2022-02-28T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Ultralife files audited Excell financials: $18.5M sales, $1.5M net income for Feb-Dec 2021 stub","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sales $18.46M, gross profit $4.32M (23.4% margin), net income $1.49M for period Feb 1-Dec 12, 2021.","Total assets $9.0M, equity $6.45M; cash $736K, accounts receivable $3.57M, inventory $3.44M.","Auditor MNP LLP issued qualified opinion unable to audit opening inventory affecting cost of sales.","Company paid $4.78M dividends and repaid $729K shareholder advances during stub period.","Acquisition closed Dec 13, 2021; financials now filed via Form 8-K/A."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":399661,"accession_number":"0001437749-22-002307","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2022-02-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q4 revenue $23.8M, operating loss $1.2M; supply chain delays impacted results","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss $1.1M ($0.07 loss per share) vs net income $2.1M ($0.13 EPS) in Q4 2020.","Revenue down 18% to $23.8M; delayed shipments from supply chain issues reduced revenue by ~$5.4M.","Backlog grew 35% core YoY to >$53M; over $63M including Excell acquisition.","FY2021 GAAP EPS ($0.01), Adjusted EPS ($0.02) vs FY2020 GAAP EPS $0.33, Adjusted EPS $0.41.","Acquisition of Excell Battery Group in Dec 2021 added initial revenue but also $0.5M in one-time expenses and purchase accounting adjustments."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":98267000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418652,"accession_number":"0001437749-21-028699","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2021-12-16T23:59:59+00:00","items":["1.01","2.01","2.03","7.01","9.01"],"status":"ready","headline":"Ultralife acquires Excell Battery Group for $23.5M; expects EPS accretion within 12 months","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total purchase price of $23.5M for Excell Canada and Excell USA; funded by cash and new credit facilities.","Excell generated $21.2M revenue for trailing twelve months ended Nov 30, 2021.","Acquisition expected to be accretive on EPS basis within twelve months; expands commercial revenue diversification.","Amended credit agreement: $10M term loan (5-year) and $30M revolver extended to May 2025, with potential increase to $50M.","Excell serves industrial markets: downhole drilling, OEM medical, mining, marine; brings experienced technical resources."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":418651,"accession_number":"0001437749-21-024453","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2021-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife reports Q3 operating loss of $0.8M; revenue down 11% to $21.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $0.6M ($0.04/diluted share); adjusted EPS unfavorably impacted by $0.08 from supply chain delays.","Revenue $21.8M, down 10.7% YoY; commercial sales up 5%, government/defense sales down 40%.","Delayed shipments from supply chain bottlenecks adversely impacted revenue by ~$4.1M in Q3.","Backlog increased ~22% sequentially; cash $15.9M, up 49% from year-end 2020; debt reduced to $0.3M.","Battery & Energy revenue down 8% to $20.0M; Communications Systems down 31% to $1.8M."],"consensus_eps_estimate":null,"consensus_eps_actual":6.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":74504000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":436211,"accession_number":"0001437749-21-017813","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2021-07-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ultralife Q2 revenue $26.8M (-6.3% YoY); EPS $0.05 vs $0.10, supply chain delays","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $26.8M, down 6.3% YoY; operating income $1.1M vs $2.3M last year.","Net income $0.8M or $0.05 diluted EPS vs $1.7M or $0.10 YoY; adjusted EPS $0.06 vs $0.13.","Battery & Energy Products revenue $22.9M (-4.8%); Communications Systems $3.9M (-13.9%).","Supply chain delays caused estimated $1.5M revenue and $0.5M operating income impact in Q2.","Cash increased to $15.8M; debt reduced to $0.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":9.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":52743000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":436210,"accession_number":"0001437749-21-017440","cik":875657,"company_name":"ULTRALIFE CORP","ticker":"ULBI","form_type":"8-K","filed_at":"2021-07-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Ultralife shareholders elect directors, approve incentive plan increase, ratify auditor at 2021 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected; Michael D. Popielec received 11,527,351 'For' votes.","Amendment to 2014 Long-Term Incentive Plan approved: 11,157,391 for, 463,629 against.","Ratification of Freed Maxick CPAs, P.C. as auditor: 13,868,292 for, 12,368 against.","13,897,805 shares present (86.6% of outstanding), quorum achieved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":109184470.01785713,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}